View in EDS PDF Full Text

SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development.
Authors: Zarei, Mahboubeh1, Zakeri, Alireza2, Khalili, Saeed2 saeed.khalili@sru.ac.ir, Hashemi, Zahra Sadat3
Source: Vaccine Research. 2023, Vol. 10 Issue 1, p1-5. 5p.
Database: Academic Search Ultimate
Description
ISSN:23832819
DOI:10.61186/vacres.10.1.1